1. NCD Risk Factor Collaboration (NCD RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. The Lancet. 2024;403(10431):1027-1050. https://doi.org/10.1016/S0140-6736(23)02750-2

2. UNICEF. Feeding profit: how food environments are failing children- 2025 Child Nutrition Report. September 2025 [Internet]. Available from: https://data.unicef.org/resources/feeding-profit-2025-child-nutrition-report/

3. Kholmatova K., Krettek A., Dvoryashina I.V., Malyutina S., Kudryavtsev A.V. Assessing the prevalence of obesity in a Russian adult population by six indices and their associations with hypertension, diabetes mellitus and hypercholesterolaemia. International Journal of Circumpolar Health. 2024;83(1):2386783. https://doi.org/10.1080/22423982.2024.2386783

4. Баланова Ю.А., Шальнова С.А., Имаева А.Э., Куценко В.А., Капустина А.В., Муромцева Г.А. и др. Ожирение в российской популяции: вклад в выживаемость и возникновение сердечно сосудистых событий. Данные исследований ЭССЕ РФ и ЭССЕ РФ2. Кардиоваскулярная терапия и профилактика. 2025;24(6):22-34. [Balanova Yu.A., Shalnova S.A., Imaeva A.E., Kutsenko V.A., Kapustina A.V., Muromtseva G.A. et al. Obesity in the Russian population: contribution to survival and occurrence of cardiovascular events. Data from the ESSE RF and ESSE RF2 studies. Cardiovascular Therapy and Prevention. 2025;24(6):22-34. (In Russ.)]. https://doi.org/10.15829/1728-8800-2025-4336

5. Powell-Wiley T.M., Poirier P., Burke L.E., Després J.P., Gordon-Larsen P., Lavie C.J. et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984-e1010. https://doi.org/10.1161/CIR.0000000000000973

6. Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. https://doi.org/10.1002/hep.28431

7. Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., Straif K. Body fatness and cancer — viewpoint of the IARC Working Group. The New England Journal of Medicine. 2016;375(8):794-798. https://doi.org/10.1056/NEJMsr1606602

8. Esperouz F., Ciavarella D., Di Gioia C., Serviddio G., Lorusso M., Lo Russo L. Is obesity a risk factor for periodontitis? A systematic review and meta analysis. Obesity Reviews. 2026;27(2):e70020. https://doi.org/10.1111/obr.70020

9. Wang Q., Li H., Huan Y., Zhou T., Zhang J., Fang R. et al. Adipose tissue: an inflammatory organ that cannot be ignored in periodontal disease related to obesity. Frontiers in Immunology. 2025;16:1698207. https://doi.org/10.3389/fimmu.2025.1698207

10. Abu-Shawish G., Betsy J., Anil S. Is obesity a risk factor for periodontal disease in adults? A systematic review. International journal of environmental research and public health. 2022;19(19):12684. https://doi.org/10.3390/ijerph191912684

11. Титова В.В., Ушанова Ф.О., Демидова Т.Ю. Медикаментозная терапия ожирения: современные подходы и перспективы. FOCUS Эндокринология. 2024;5(4):40-48. [Titova V.V., Ushanova F.O., Demidova T.Yu. Medical treatment of obesity: Modern approaches and prospects. FOCUS. Endocrinology. 2024;5(4):40-48. (In Russ.)]. https://doi.org/10.62751/2713-0177-2024-5-4-18

12. Ghosal S., Heron N., Mason K.J., Bailey J., Jordan K.P. Weight management with orlistat in type 2 diabetes: an electronic health records study. The British journal of general practice. 2024;74(748):758-766. https://doi.org/10.3399/BJGP.2023.0684

13. Берковская М.А., Гурова О.Ю., Суркова Е.В., Фадеев В.В. История медикаментозного лечения ожирения. Проблемы Эндокринологии. 2025;71(2):82-92. [Berkovskaya M.A., Gurova O.Yu., Surkova E.V., Fadeev V.V. History of pharmacological treatment of obesity. Problems of Endocrinology. 2025;71(2):82–92. (In Russ.)]. https://doi.org/10.14341/probl13469